Hygropax

Chlortalidone, the active ingredient in Hygropax, is a thiazide-like diuretic presented as a tablet for oral use. It treats hypertension and edema in adults.

GNH USA supplies Hygropax as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Chlortalidone is a thiazide-like diuretic used to manage conditions involving fluid overload and high blood pressure.

- Hypertension: lowers systolic and diastolic blood pressure by reducing plasma volume. - Edema: promotes the excretion of excess fluid associated with heart, liver or kidney disease. - Congestive heart failure: assists in controlling fluid retention and improving symptoms.

Chlortalidone may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Increased urination: frequent need to void. - Electrolyte imbalance: low potassium or sodium levels. - Dizziness or light‑headedness, especially on standing. - Headache. - Fatigue. - Mild gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe dehydration or hypovolemia. - Marked electrolyte disturbances (e.g., severe hypokalemia, hyponatremia). - Acute gout attacks. - Pancreatitis. - Severe allergic reactions such as rash or angioedema. - Blood dyscrasias including agranulocytosis.

When prescribing or dispensing chlortalidone, several safety considerations are recommended.

- Renal function: assess baseline kidney function and monitor periodically. - Electrolytes: check serum potassium and sodium before initiation and during therapy. - Gout history: be aware that uric acid levels may rise, potentially triggering attacks. - Diabetes mellitus: monitor blood glucose as diuresis can affect glycemic control. - Pregnancy: safety not established; use only if potential benefit justifies risk. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Chlortalidone can interact with several drug classes, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Lithium: concurrent use may increase lithium levels and toxicity. - NSAIDs: may blunt the diuretic’s antihypertensive effect. - ACE inhibitors or ARBs: combined therapy can cause profound hypotension and renal impairment. - Corticosteroids: may enhance potassium loss.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: diuresis may affect glucose control, requiring dose adjustment. - Beta‑blockers: additive blood‑pressure‑lowering effect. - Digoxin: electrolyte shifts can increase the risk of digoxin toxicity.